| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.263 | 4.716 | 3.393 | 4.255 | 2.845 | 4.324 | 8.711 | 4.725 | 8.872 | 1.643 |
| Total Income - EUR | 2.263 | 4.716 | 3.393 | 4.255 | 2.845 | 4.324 | 8.711 | 4.725 | 8.872 | 1.643 |
| Total Expenses - EUR | 7.149 | 5.888 | 3.792 | 4.653 | 6.123 | 6.745 | 6.915 | 7.976 | 8.273 | 5.944 |
| Gross Profit/Loss - EUR | -4.886 | -1.172 | -399 | -398 | -3.278 | -2.421 | 1.795 | -3.251 | 599 | -4.301 |
| Net Profit/Loss - EUR | -4.954 | -1.313 | -500 | -526 | -3.364 | -2.503 | 1.534 | -3.392 | 511 | -4.317 |
| Employees | 2 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Korpagrobiologik Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.291 | 3.258 | 2.557 | 2.510 | 2.461 | 2.415 | 2.361 | 2.368 | 2.361 | 2.348 |
| Current Assets | 793 | 1.751 | 1.835 | 1.147 | 44 | 465 | 1.859 | 1.446 | 1.996 | 12 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 793 | 1.751 | 1.835 | 1.147 | 44 | 465 | 1.859 | 1.446 | 1.996 | 12 |
| Shareholders Funds | -6.161 | -7.411 | -7.786 | -8.169 | -11.374 | -13.662 | -11.825 | -15.254 | -14.697 | -18.933 |
| Social Capital | 10.799 | 10.689 | 10.508 | 10.315 | 10.115 | 9.923 | 9.703 | 9.733 | 9.704 | 9.650 |
| Debts | 11.245 | 12.421 | 12.178 | 11.826 | 13.880 | 16.542 | 16.045 | 19.069 | 19.055 | 21.292 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "150 - 150" | |||||||||
| CAEN Financial Year |
150
|
|||||||||
Comments - Korpagrobiologik Srl